Trial Profile
Guideline for the Treatment of Newly Diagnosed Patients Eith Acutypromyelocytic Leukemia, Aged > 12 Months (1 Year) and <75 Years, Using All-trans Retinoic Acid in Combination With Idarubicin
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Oct 2022
Price :
$35
*
At a glance
- Drugs Tretinoin (Primary) ; Idarubicin; Mercaptopurine; Methotrexate
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- Acronyms AIDA
- 19 Feb 2010 New trial record